Topical creams are becoming part of the mix of pain treatment options as doctors look for alternatives to addictive opioids.
Discover how to prevent Medicare from disrupting your settled claims. Learn when MSAs are needed, what documentation to gather upfront, and strategic approaches to identify cost drivers.
As the workforce ages, workers’ comp claims grow more complex. Enlyte experts share insights on case management, ergonomics, and return to work strategies.
Gabapentin was approved by the Food and Drug Administration (FDA) decades ago for seizures and nerve pain. Today, it is one of the most commonly prescribed drugs in the United States.
After several years of steady growth, the battery electric vehicle (BEV) market experienced significant volatility in 2025. Automotive manufacturers scaled back investments—including Ford with its F-150 Lightning end of production announcement—and the U.S. and Canada rescinded tax credits designed to boost consumer demand for BEVs. While brands like GM, Honda and Volkswagen experienced modest BEV sales gains, overall adoption slowed. In the U.S., BEV purchases declined by approximately 2% from 2024 and with more electrified alternatives, Tesla’s market share also dropped to 46.2% from 48.7% in 2024.
Mitchell published its latest Plugged-In: EV Collision Insights report today. This issue provides an overview of the most notable 2025 trends in collision claims and repair for battery electric vehicles (BEVs), plug-in hybrid electric vehicles (PHEVs) and mild hybrid electric vehicles (MHEVs). While sales of new BEVs decreased approximately 2% in the U.S., claims for repairable vehicles kept climbing.
As third-party litigation funding drives higher claims costs and rising premiums, find out what’s being done to curb the impact. Hear from Brian Allen and Michele Hibbert on the legislative efforts taking shape in 2026 to protect insurers and consumers.